Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Aldape

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2017
Insights From Molecular Profiling of Adult GliomaPhedias Diamandis, Kenneth D Aldape
The Journal of Pathology|October 12, 2013
Using the molecular classification of glioblastoma to inform personalized treatmentAdriana Olar, Kenneth D Aldape
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2016
PCR Techniques in Characterizing DNA MethylationKhalida Wani, Kenneth D Aldape
Current Treatment Options in Oncology|September 8, 2012
Biomarkers classification and therapeutic decision-making for malignant gliomasAdriana Olar, Kenneth D Aldape
Journal of Neuro-Oncology|February 21, 2023
Molecular classification and grading of meningiomaMacLean P Nasrallah, Kenneth D Aldape
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
The evolving role of molecular markers in the diagnosis and management of diffuse gliomaJason T Huse, Kenneth D Aldape
Expert Opinion on Medical Diagnostics|October 29, 2013
The molecular landscape of diffuse glioma and prospects for biomarker developmentJason T Huse, Kenneth D Aldape
Cancer Cell|December 13, 2017
Glut3 Addiction: A Druggable Vulnerability in GlioblastomaSevera Bunda, Gelareh Zadeh, Kenneth D Aldape
Neurosurgical Focus|December 2, 2014
Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastomaSameer Agnihotri, Kenneth D Aldape, Gelareh Zadeh
Nature Biotechnology|June 10, 2003
A model of molecular interactions on short oligonucleotide microarraysLi Zhang, Michael F Miles, Kenneth D Aldape
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2017
Insights From Molecular Profiling of Adult GliomaPhedias Diamandis, Kenneth D Aldape
The Journal of Pathology|October 12, 2013
Using the molecular classification of glioblastoma to inform personalized treatmentAdriana Olar, Kenneth D Aldape
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2016
PCR Techniques in Characterizing DNA MethylationKhalida Wani, Kenneth D Aldape
Current Treatment Options in Oncology|September 8, 2012
Biomarkers classification and therapeutic decision-making for malignant gliomasAdriana Olar, Kenneth D Aldape
Journal of Neuro-Oncology|February 21, 2023
Molecular classification and grading of meningiomaMacLean P Nasrallah, Kenneth D Aldape
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
The evolving role of molecular markers in the diagnosis and management of diffuse gliomaJason T Huse, Kenneth D Aldape
Expert Opinion on Medical Diagnostics|October 29, 2013
The molecular landscape of diffuse glioma and prospects for biomarker developmentJason T Huse, Kenneth D Aldape
Cancer Cell|December 13, 2017
Glut3 Addiction: A Druggable Vulnerability in GlioblastomaSevera Bunda, Gelareh Zadeh, Kenneth D Aldape
Neurosurgical Focus|December 2, 2014
Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastomaSameer Agnihotri, Kenneth D Aldape, Gelareh Zadeh
Nature Biotechnology|June 10, 2003
A model of molecular interactions on short oligonucleotide microarraysLi Zhang, Michael F Miles, Kenneth D Aldape
Pageof 20